16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome

Autor: Jessica Richman, Laurens Kraal, Elisabeth M. Bik, Juan Pablo Cárdenas, Yelena V. Budovskaya, Daniel Almonacid, Francisco J. Ossandon, Zachary Apte, Audrey D. Goddard
Rok vydání: 2016
Předmět:
Bacterial Diseases
0301 basic medicine
Molecular biology
lcsh:Medicine
Gene Sequencing
Disease
Pathology and Laboratory Medicine
Biochemistry
law.invention
Database and Informatics Methods
Probiotic
Sequencing techniques
Salmonella
law
Reference Values
RNA
Ribosomal
16S

Medicine and Health Sciences
DNA sequencing
lcsh:Science
Multidisciplinary
Genomics
Bacterial Pathogens
Nucleic acids
Infectious Diseases
Salmonella Enterica
Ribosomal RNA
Medical Microbiology
Pathogens
Sequence Analysis
Research Article
Cell biology
Cellular structures and organelles
Bioinformatics
Clostridium Difficile
030106 microbiology
Sequence Databases
Reference range
Context (language use)
Microbial Genomics
Computational biology
Biology
Research and Analysis Methods
Microbiology
03 medical and health sciences
Enterobacteriaceae
Genetics
Humans
Microbiome
Non-coding RNA
Microbial Pathogens
Biology and life sciences
Bacteria
Sequence Analysis
RNA

lcsh:R
Gut Bacteria
Organisms
Correction
16S ribosomal RNA
Gastrointestinal Microbiome
Molecular biology techniques
Biological Databases
030104 developmental biology
RNA
lcsh:Q
Ribosomes
Zdroj: PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176555 (2017)
PLoS ONE, Vol 14, Iss 2, p e0212474 (2019)
ISSN: 1932-6203
Popis: Changes in the relative abundances of many intestinal microorganisms, both those that naturally occur in the human gut microbiome and those that are considered pathogens, have been associated with a range of diseases. To more accurately diagnose health conditions, medical practitioners could benefit from a molecular, culture-independent assay for the quantification of these microorganisms in the context of a healthy reference range. Here we present the targeted sequencing of the microbial 16S rRNA gene of clinically relevant gut microorganisms as a method to provide a gut screening test that could assist in the clinical diagnosis of certain health conditions. We evaluated the possibility of detecting 46 clinical prokaryotic targets in the human gut, 28 of which could be identified with high precision and sensitivity by a bioinformatics pipeline that includes sequence analysis and taxonomic annotation. These targets included 20 commensal, 3 beneficial (probiotic), and 5 pathogenic intestinal microbial taxa. Using stool microbiome samples from a cohort of 897 healthy individuals, we established a reference range defining clinically relevant relative levels for each of the 28 targets. Our assay quantifies 28 targets in the context of a healthy reference range and correctly reflected 38/38 verification samples of real and synthetic stool material containing known gut pathogens. Thus, we have established a method to determine microbiome composition with a focus on clinically relevant taxa, which has the potential to contribute to patient diagnosis, treatment, and monitoring. More broadly, our method can facilitate epidemiological studies of the microbiome as it relates to overall human health and disease.
Databáze: OpenAIRE